Pharmaron Beijing Co., Ltd. (03759)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Chen Guoqin27-Oct-1623-Sep-22INEDDue to the upcoming expiration of her six-year consecutive term of office as required according to the Rules for Independent Directors of Listed Companies of the China Securities Regulatory Commission
Chen Pingjin13-Oct-1721-Jun-23NED
Dai Lixin27-Oct-1623-Sep-22INEDDue to the upcoming expiration of his six-year consecutive term of office as required according to the Rules for Independent Directors of Listed Companies of the China Securities Regulatory Commission
Feng Shu11-Dec-20Sup
Hu Baifeng13-Oct-1725-Apr-24NEDVoluntary resignation due to reallocation of his primary work responsibilities.
Li Jiaqing27-Oct-16NED
Li Lihua23-Sep-22INED
27-Oct-1623-Jul-20INED
Li Shing Chung Gilbert18-Dec-25Emp. Dir.
01-Jan-15CFO
Liu Jun13-Oct-1711-Dec-20Sup
Lou Boliang27-Oct-16Ch, CEO, Co-Fdr, ED
Lou Xiaoqiang27-Oct-16Co-Fdr, Pres, ED
Mak Cherie Po Man25-Apr-24CoSecNo reasons provided
Mak Po Man Cherie30-Mar-26CoSec, AuRep, Proc Agt
Shen Rong12-Jun-26INED
Shen Rong27-Oct-1623-Jul-20INED
Tsang Benson Kwan Hung28-Nov-1928-Oct-25INEDMr. Tsang Kwan Hung Benson has tendered his resignation as his tenure is approaching six years. The consecutive terms of office of an independent director shall generally not exceed six years.; as per CSRC regulations.
Yang Kexin27-Oct-16ChSup
Yim Issac Lok Kwan25-Apr-2430-Mar-26CoSecMr. Yim has tendered his resignation.
30-Mar-26AuRep, Proc AgtMr. Yim has tendered his resignation.
Yu Jian23-Jul-20INED
Zhang Lan27-Oct-16Sup
Zheng Bei27-Oct-16Co-Fdr, ED, VP
Zhou Hongbin27-Oct-1621-Jun-23NED
Zhou Qilin23-Sep-2227-Nov-24INEDResignation in compliance with the relevant rules on the part-time management of members of the Chinese Academy of Engineering. Mr. Zhou confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the Stock Exchange or the shareholders of the Company.